Effects of Pretreatment With Ibuprofen in Post-Electroconvulsive Therapy (ECT) Headache
The purpose of the study is to determine whether ibuprofen reduces post-ECT headache or reduces its severity...
Brief Summary
Official Title: “Effects of Pretreatment With Ibuprofen in Post- ECT Headache”
The purpose of the study is to determine whether ibuprofen reduces post-ECT headache or reduces its severity.
- Study Type: Interventional
- Study Design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment
- Study Primary Completion Date: January 2013
Detailed Clinical Trial Description
The aim of the study is to compare the severity of headache between patients who are receiving ibuprofen prior to ECT treatment with patients receiving placebo prior to ECT treatment.
Patients will be randomly assigned to receive either 600 mg ibuprofen 90 min prior to treatment or placebo orally, blinded to patient, physician and treatment team.
Patients will be asked about their headache with a visual analogue scale (VAS) 2 hours prior to and within 2 hours after treatment, 2-month, 6- month and 1 year follow-up [5].
Intervention(s) in this Clinical Trial
- Drug: Ibuprofen
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Patients receiving ECT
Exclusion Criteria:
- Pregnancy, contraindications to ibuprofen
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 18 Years
Maximum Age for this Clinical Trial: N/A
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Investigator Information
Lead Investigator: Norwegian University of Science and Technology Other
Overall Clinical Trial Officials and Contacts
Olav Morten Linaker, MD PhD Principal Investigator Norwegian University of Science and Technology
Overall Contact: Lindy Jarosch-von Schweder, MD 47 73864533 lindy.jarosch@ntnu.no
Additional Information
Information obtained from ClinicalTrials.gov on February 12, 2012
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00258791
Study ID Number: LVS-2005
ClinicalTrials.gov Identifier: NCT00258791
Health Authority: Norway: Norwegian Social Science Data Services
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00258791
